Email Updates

You are here

AVAC in the News

  • HIVR4P // Virtual was held over the course of two weeks on 27-28 January and 3-4 February 2021 as the COVID-19 pandemic continued to inflict unprecedented harm globally. The HIVR4P community came together with 1,802 researchers, care providers, policy-makers, implementors and advocates from 92 countries whose expertise spanned the breadth of the HIV prevention pipeline from pre-clinical to implementation. The program included 113 oral and 266 poster presentations. This article presents a brief summary of the conference highlights.

    October 29, 2021
    AIDS Research and Human Retroviruses
  • COVID-19 has now killed about 730,000 people in the US, making it the deadliest pandemic in the nation's history, with more lives claimed than by HIV/AIDS. The tally comes as the US marks four decades since HIV — the virus that can cause AIDS — was first detected in the country, and some are now looking at the two vastly different diseases and seeing parallels. The US government's initial approach to both HIV/AIDS and COVID was denial and indifference.

    October 21, 2021
    The National News
  • It is paradoxical that the speed in obtaining vaccines against COVID-19 is due, in large part, to the enormous advantage provided by research on HIV and its key technologies and that, however, we still continue without an immunization against the virus AIDS. To move forward, we need increased funding and consistent commitment from the industry.

    October 14, 2021
    Agencia SINC
  • In June, we reported that PEPFAR, the $7 billion US global-AIDS relief program started by President George W. Bush in 2003, had been leaderless for more than a year. This left global AIDS advocates worried that the program was losing momentum and focus, especially amid the new global pandemic of COVID-19.

    October 12, 2021
  • Researchers plan to use a series of shots to teach people’s immune systems to produce powerful antibody responses against the virus. But while the strategy is raising hopes and is built on years of research, there’s no guarantee it succeeds.

    October 7, 2021
    San Diego Union-Tribune
  • Just how will the Africa Centres for Disease Control (Africa CDC) run after its famed leader John Nkengasong leaves? The answer may not be apparent, but the Cameroonian-American virologist, who has recently become the face of Africa’s campaign for vaccine equity, could be departing the organisation soon.

    September 28, 2021
    The East African
  • For the first time in its 18-year history, the President’s Emergency Plan For AIDS Relief (PEPFAR) will be headed by an African public health leader, according to a report in the New York Times. President Joe Biden plans to appoint John Nkengasong, MD, as head of the federal agency that serves people living with HIV worldwide.

    September 27, 2021
  • United States President Joe Biden is reportedly nominating Dr. John Nkengasong, director of the Africa Centres for Disease Control and Prevention, to head the US President’s Emergency Plan for AIDS Relief, a $7 billion operation. The US government initiative has been without a leader since February. The Cameroonian virologist would be the first person from the African continent to head the program.

    September 22, 2021
  • The Biden administration plans to nominate John Nkengasong, a virologist and director of the Africa Centers for Disease Control and Prevention, to lead the President’s Emergency Plan for AIDS Relief, according to several sources familiar with the matter.

    September 21, 2021
    New York Times
  • Vaccines were promoted as a silver bullet to end the pandemic, the path to finally beating COVID-19. But in Africa, they remain scarce, with access hampered by hoarding, export bans and empty promises. Nearly six billion vaccine doses have been administered globally, but only two percent of those have been in Africa.

    September 21, 2021
    France 24